LIGAND PHARMACEUTICALS INC (LGND)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LGND
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LGND | Chief Executive Officer of Ligand Pharmaceuticals Incorporated | 65 | ["Co-Founder and Former Managing Partner of HealthCare Royalty Partners (now HCRx)"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PVLA | Director | 64 | ["Chief Executive Officer of Ligand Pharmaceuticals Incorporated since December 2022","Founder and managing partner of RoyaltyRx Capital, LLC since September 2018","Co-founder and Managing Partner of Cowen/HealthCare Royalty Partners from 2006 to January 2018","Partner at Paul Capital Partners from 2004 to 2006","Partner responsible for biopharmaceutical growth equity investments at Apax Partners from 2001 to 2004","Held various sales and product management roles at Abbott Laboratories from 1990 to 1995","General management, business development, and licensing roles at Elan Pharmaceuticals, LLC from 1997 to 2001","Extensive experience in healthcare industry and healthcare investment management","Experience as a director of a publicly held biopharmaceutical company"] | ["Compensation","Nominating and Corporate Governance"] | 2025 |
Biography sourced from the proxy statement filing.
Chief Executive Officer of Ligand Pharmaceuticals Incorporated Co-Founder and Former Managing Partner of HealthCare Royalty Partners (now HCRx)